ResearcherSichuan UniversityActive in the last 2 years

Ang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8269-7232; OpenAlex author ID A5100413584. Sources: OpenAlex.

Their work

Papers: 4
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 11

Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: none · 2023: 1 paper · 2024: none · 2025: 1 paper

Papers 4

Proteomics in pancreatic cancer. Co-author DOI 10.1186/s40364-025-00805-y ↗
Retraction: Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels. Co-author DOI 10.18632/aging.204491 ↗
Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels. Co-author DOI 10.18632/aging.202847 ↗
Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and PTEN. Co-author DOI 10.1016/j.yexcr.2017.10.033 ↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhen You · 1 shared paper, 2023 · strength 0.22
- Paper Retraction: Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels. DOI 10.18632/aging.204491 ↗
Fei Cai · 1 shared paper, 2025 · strength 0.20
- Paper Proteomics in pancreatic cancer. DOI 10.1186/s40364-025-00805-y ↗
Yong Zhang · 1 shared paper, 2025 · strength 0.20
- Paper Proteomics in pancreatic cancer. DOI 10.1186/s40364-025-00805-y ↗
Zhen You · 1 shared paper, 2021 · strength 0.16
- Paper Downregulation of OIP5-AS1 affects proNGF-induced pancreatic cancer metastasis by inhibiting p75NTR levels. DOI 10.18632/aging.202847 ↗
Xu-Bao Liu · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Ailin Wei · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Weiming Hu · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Junjie Xiong · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Chunlu Tan · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Dan Wang · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗
Huimin Lü · 1 shared paper, 2017 · strength 0.06
- Paper Deregulated expression of miR-107 inhibits metastasis of PDAC through inhibition PI3K/Akt signaling via caveolin-1 and … DOI 10.1016/j.yexcr.2017.10.033 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.